Prader-Willi Syndrome clinical trials at University of California Health
2 in progress, 0 open to eligible people
Showing trials for
DCCR in Patients With Prader-Willi Syndrome
Sorry, in progress, not accepting new patients
The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.
at UC Irvine
DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
Sorry, in progress, not accepting new patients
This is a multi-center, multi-period study with an open-label period followed by a double-blind, placebo-controlled, randomized withdrawal period evaluating the safety and efficacy of DCCR treatment.
at UC Irvine
Last updated: